StockData

Yubo International Biotech Ltd (YBGJ) stock

YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.01+0.00 (0.00%)

Close on Oct 16, 2026Market cap $886.19KP/E –Yield –

What Yubo International Biotech keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin66.1%vs 55.4%
Operating margin-9096.9%vs -5.17%
EBITDA margin-8197.4%vs -2.67%
Pretax margin-9386.8%vs -2.76%
Net margin-8157.3%vs -10.3%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-116.9%vs -12.2%

How hard the assets work

Revenue per dollar of assets0.01vs 0.58
Inventory turns a year0.13vs 2.23

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $11.99K.

Cash and short-term investments$11.99K
EBITDA, trailing twelve months-$1.01M

Leverage and liquidity

Current ratio0.18vs 2.50
Quick ratio0.05vs 1.55

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

4 of 9 tests passed

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 16, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

YBGJS&P 500
PeriodYBGJS&P 500DifferenceYBGJ per yearS&P 500 per year
1 month-1.9%+1.5%−3.4 pts
3 months-65.1%+1.9%−67.0 pts
Year to date-58.1%+12.8%−70.9 pts
1 year-61.8%+16.8%−78.5 pts
3 years-99.0%+81.5%−180.5 pts-78.7%+22.0%
5 years-98.9%+83.0%−181.9 pts-59.2%+12.8%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M YBGJ shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20261140.0%2,4551.0
Oct 15, 20261140.0%1114.0
Sep 30, 20261140.0%1,6351.0
Sep 15, 20261140.0%1,9001.0
Aug 31, 20261140.0%7271.0
Aug 14, 20261140.0%3,4201.0
Jul 31, 20261140.0%3331.0
Jul 15, 20261140.0%21,5511.0
Jun 30, 20261140.0%18,0911.0
Jun 15, 20261140.0%01000.0
May 29, 20261140.0%428.5
May 15, 20261140.0%01000.0

Every measure, in full

32 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
37.6%
3.51%
Float
43M
38M
Shares Held by Insiders
74.9%
10.4%

MarginsIndustry

Gross Margin
66.1%
55.4%
Operating Margin
-9096.9%
-5.17%
Pretax Margin
-9386.8%
-2.76%
Profit Margin
-8157.3%
-10.3%
EBITDA Margin
-8197.4%
-2.67%

Returns on capitalIndustry

Return on Assets (ROA)
-116.9%
-12.2%

Financial positionIndustry

Current Ratio
0.18
2.50
Quick Ratio
0.05
1.55

GrowthIndustry

Revenue Growth (3Y CAGR)
-50.9%
7.08%

EfficiencyIndustry

Asset Turnover
0.01
0.58
Inventory Turnover
0.13
2.23

Income statement (TTM)Industry

Revenue
$12.35K
$104.77M
Gross Profit
$8.17K
$61.99M
Operating Income
-$1.12M
-$3.82M
Pretax Income
-$1.16M
-$2.12M
Net Income
-$1.01M
-$6.19M
EBITDA
-$1.01M
-$2.02M
EPS (Diluted)
$0.00
-$0.08

Balance sheetIndustry

Net Cash (Debt)
$11.99K
$3.73M
Net Cash Per Share
$0.00
$0.28
Equity (Book Value)
-$2.62M
$63.83M
Book Value Per Share
-$0.02
$2.98
Tangible Book Value
-$2.66M
$10.75M
Working Capital
-$2.74M
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
-$727.99K
-$463.66K

Taxes and interestIndustry

Income Tax
$0
$1.52M

Scores and fair valueIndustry

Piotroski F-Score
4
5

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?